234 related articles for article (PubMed ID: 16773719)
41. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.
Ro Y; Muramatsu T; Shima K; Yajima Y; Shibahara T; Noma H; Shimono M
Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239
[TBL] [Abstract][Full Text] [Related]
42. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
[TBL] [Abstract][Full Text] [Related]
43. Molecular histogenesis of plasmablastic lymphoma of the oral cavity.
Gaidano G; Cerri M; Capello D; Berra E; Deambrogi C; Rossi D; Larocca LM; Campo E; Gloghini A; Tirelli U; Carbone A
Br J Haematol; 2002 Dec; 119(3):622-8. PubMed ID: 12437635
[TBL] [Abstract][Full Text] [Related]
44. Falsely elevated anti-tissue transglutaminase antibodies in patients with immunoproliferative small intestinal diseases: A case series.
Mohta S; Agarwal A; Banyal V; Singh A; Bagchi S; Das P; Ahuja V; Makharia G
Indian J Gastroenterol; 2023 Oct; 42(5):713-717. PubMed ID: 37166700
[TBL] [Abstract][Full Text] [Related]
45. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
46. The evolution of alpha heavy chain disease.
Guardia J; Rubies-Prat J; Gallart MT; Moragas A; Martinez-Vazquez JM; Bacardi R; Vilaseca J
Am J Med; 1976 Apr; 60(4):596-602. PubMed ID: 818898
[TBL] [Abstract][Full Text] [Related]
47. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
[TBL] [Abstract][Full Text] [Related]
48. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
[TBL] [Abstract][Full Text] [Related]
49. Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.
Rimsza LM; Day WA; McGinn S; Pedata A; Natkunam Y; Warnke R; Cook JR; Marafioti T; Grogan TM
Diagn Pathol; 2014 Jul; 9():144. PubMed ID: 25047073
[TBL] [Abstract][Full Text] [Related]
50. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
51. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
52. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
53. Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
Pai RK; Snider WK; Starkey CR; Viswanatha D; Foucar MK; Wilson CS
Arch Pathol Lab Med; 2005 Nov; 129(11):1487-90. PubMed ID: 16253033
[TBL] [Abstract][Full Text] [Related]
54. IgA plasmablastic large B-cell lymphoma.
Roncati L; Maiorana A
Diagnosis (Berl); 2017 Jun; 4(2):105-107. PubMed ID: 29536914
[No Abstract] [Full Text] [Related]
55. Immunoproliferative small intestinal disease with duodenojejunal lymphoma: radiologic changes.
Vessal K; Dutz W; Kohout E; Rezvani L
AJR Am J Roentgenol; 1980 Sep; 135(3):491-7. PubMed ID: 6773368
[TBL] [Abstract][Full Text] [Related]
56. Immunoproliferative small intestinal disease in Algerians. I. Light microscopic and immunochemical studies.
Asselah F; Slavin G; Sowter G; Asselah H
Cancer; 1983 Jul; 52(2):227-37. PubMed ID: 6407746
[TBL] [Abstract][Full Text] [Related]
57. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
[TBL] [Abstract][Full Text] [Related]
58. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.
Kaleem Z; Zehnbauer BA; White G; Zutter MM
Am J Clin Pathol; 2000 Mar; 113(3):399-405. PubMed ID: 10705821
[TBL] [Abstract][Full Text] [Related]
59. [Detection of Immunoglobulin light chain restriction of mucosa-associated lymphoid tissue type gastric lymphoma using mRNA in situ hybridization].
Zhang Y; Ho FC; Shen D; Xu W; Chan AC; Srivastava G
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):31-4. PubMed ID: 11866954
[TBL] [Abstract][Full Text] [Related]
60. Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.
Tomita N; Takeuchi K; Hyo R; Hashimoto C; Takemura S; Taguchi J; Fujita H; Fujisawa S; Ogawa K; Motomura S; Ishigatsubo Y
Acta Haematol; 2009; 121(4):196-201. PubMed ID: 19468204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
